Earnings
Super Micro Computer earnings preview: Margins in focus after revenue miss
Investors will scrutinize margins as Super Micro Computer reports quarterly results amid concerns over revenue growth and cost pressures.
Brinker International Q4 earnings, FY27 outlook in focus
Restaurant operator Brinker International reports quarterly results amid investor scrutiny of its full-year 2027 guidance. Analysts weigh margin trends and consumer demand signals.
Franco-Nevada Q2 earnings in focus as gold price swings test royalty model
Gold price volatility over the past quarter may pressure Franco-Nevada's earnings growth despite its diversified royalty portfolio.
Performance Food Group shares rise ahead of quarterly earnings report
Food distributor faces investor scrutiny as it prepares to release quarterly results on Wednesday, with shares gaining modestly in pre-market trading.
CoreWeave earnings preview: AI infrastructure drives profit outlook
AI-focused data center operator CoreWeave reports earnings as demand for high-performance computing accelerates amid AI infrastructure buildout.
Sitowise Q2 2025 earnings mixed, shares fall
Finnish engineering firm's quarterly results miss expectations as revenue growth slows and costs rise. Shares decline in early trading.
Vestis Q3 2026 profitability rises as volume strategy shifts
Slides reveal improved margins despite strategic pivot in sales approach. Full results due Nov 10.
Nebius earnings eyed as Vineland pushes back test phase
Vineland's delay in test execution raises questions ahead of Nebius's earnings report. Investors assess impact on projected timelines.
Lumentum earnings to show AI optics demand, profitability test
Optical components supplier Lumentum faces scrutiny on margins as AI-driven demand for high-end lasers and photonic chips tests its profitability in the latest quarter.
Mineralys Therapeutics losses seen widening in next earnings
Biopharma firm reports revenue growth but deeper losses expected as R&D costs rise. Analysts project Q2 net loss of $0.25 per share.
PagSeguro Q2 earnings in focus as credit growth slows
Brazil’s fintech faces scrutiny over loan book expansion amid rising delinquencies and macroeconomic headwinds. Results due Aug 8.
Kontoor Brands reports earnings as Lee divestiture nears
Denim apparel maker Kontoor Brands to release quarterly results amid ongoing strategic review and planned separation of Lee brand.
Astronics Q2 earnings to test margins after guidance hike
Defense and aerospace supplier Astronics reports Q2 results amid margin scrutiny following an upward revision to full-year guidance.
Octave reports first earnings as independent company
The newly spun-off financial services firm is set to release its first quarterly results since separating from its former parent. Investors await key profitability and growth metrics.
Access Newswire misses earnings estimates by $0.17 per share
Revenue declines 12% year-over-year as media firm falls short of analyst forecasts in latest quarter.
Advanced Enzyme Q1 FY27 results show soft start but key segments grow
FY27 first quarter results from Advanced Enzyme indicate a slow initial period, though growth persists in several core business segments.
Gujarat Energy Q1 2026 EPS beats estimates as revenue falls short
Indian utility posts quarterly profit above forecasts despite missing revenue targets, citing higher fuel costs and regulatory delays.
Advanced Enzyme Q1 2026 earnings miss estimates, shares slide
Revenue and profit for the quarter fell short of analyst forecasts as costs rose, triggering a 5% drop in Advanced Enzyme Technologies stock.
Caplin Point shares drop 6.3% on Q1 2026 update
Indian pharmaceutical firm's stock declines after first-quarter results miss analyst expectations. Revenue and profit figures fall short of forecasts.
Neuronetics posts earnings beat, revenue exceeds forecasts
Medical device maker Neuronetics reported adjusted earnings per share above estimates, with revenue also surpassing projections despite broader sector challenges.
Inderes Q2 2026 revenue up 14%, all units grow
Finnish financial services firm reports broad-based growth across all business segments for the quarter, with revenue increasing 14% year-over-year.
C4 beats earnings estimates by $0.03, revenue misses forecasts
The company reported adjusted earnings per share of $0.32, exceeding expectations, but revenue of $1.2 billion fell short of analyst projections.
Harvard Bioscience raises 2026 guidance after Q3 beat
Medical technology firm posts quarterly earnings above expectations and lifts full-year outlook for 2026, citing strong demand in life sciences tools.
Xtant Medical misses earnings estimates on revenue shortfall
Medical device maker Xtant Medical reported adjusted EPS of $0.01, below the $0.06 forecast, as revenue declined 11% year-over-year.
